The Access Procalcitonin Study

The Access Procalcitonin (PCT) shows consistency of result interpretation compared to other commercially available testing methods A peer‐reviewed study shows the Access PCT assay has strong correlation and method concordance compared to established procalcitonin tests. Click here to find out more

Beckman Coulter – Coronavirus Update

Beckman Coulter is strongly committed to the health and well-being of our associates, customers and partners, and we are fully supportive of the containment and virus management efforts that are being implemented by countries around the globe. During this time of uncertainty, we seek to bring clarity to some of the issues concerning our associates,… Read more »


Available Now! In response to the current COVID-19 global health emergency, our partners ZeptoMetrix™ Corporation and Microbiologics Inc have both announced the development and release of a SARS-CoV-2 quality control. Targeting both the N and E-gene, AB Scientific are supporting Hospitals in the UK and Ireland to provide safe options for intact, non-infectious QC materials…. Read more »

Join Leica Biosystems virtually for the 2020 Digital Pathology Summit.

WHEN: MAY 19 – 20, 2020 Featuring thought leaders from around the globe, the digital pathology summit aims to showcase talks on the latest topics and advances in digital pathology whilst providing a collaborative and interactive experience in a virtual environment. This event is complimentary. Click here to sign up to the summit. FEATURED SPEAKERS:… Read more »

Introducing the BxChip- a pioneering method of needle core biopsy processing.

https://www.cellpath.com/ In this article, CellPath introduce an aid to biopsy processing that protects tissue and facilitates production of maximum diagnostic information- the Lumea BxChip. We also share our conversation with an early adopter of the BxChip, and hear of the success they achieved with their trials. Needle core biopsies are taken to minimise patient discomfort… Read more »


Enhancing thrombotic thrombocytopenic purpura (TTP) diagnosis through quantifying ADAMTS-13 is time consuming and technically demanding.  However, a recent multi-centre evaluation of TECHNOSCREEN® ADAMTS13 activity assay as a screening tool for detecting deficiency of ADAMTS-13 has concluded that the test provides more rapid ADAMTS-13 level evaluation than most currently available assays.  “Its simple operation renders it suitable… Read more »

Cirdan Wins Eurofins Pathology Cloud-based LIS contract

Cirdan is delighted to announce the award of a contract by Eurofins Pathology for a new generation Laboratory Information System (LIS). Eurofins Pathology is part of the wider Eurofins Scientific Group, a global leader in life sciences testing… Click here to find out more